A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
暂无分享,去创建一个
D. Cummings | J. Lessler | A. Wesolowski | D. Burke | L. Katzelnick | H. Salje | B. Solomon | I. Rodríguez-Barraquer | B. García-Carreras | M. Hitchings | Bingyi Yang | A. Huang | Brooke A Borgert | S. Rattigan | Carlos Moreno | Carlos A Moreno | Brooke A. Borgert | Bernardo García-Carreras
[1] Robert Fantina,et al. Challenges and Pitfalls , 2021, Introducing Robotic Process Automation to Your Organization.
[2] Rachel E. Baker,et al. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic , 2020, Science.
[3] Zacharias E. Andreadakis,et al. The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.
[4] Xuetao Cao. COVID-19: immunopathology and its implications for therapy , 2020, Nature Reviews Immunology.
[5] Bryan T Grenfell,et al. Susceptible supply limits the role of climate in the COVID-19 pandemic , 2020, medRxiv.
[6] C. Hillyer,et al. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses , 2020, Trends in Immunology.
[7] M. Lipsitch,et al. Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure , 2020, The Journal of infectious diseases.
[8] Guohong Deng,et al. Viral Kinetics and Antibody Responses in Patients with COVID-19 , 2020, medRxiv.
[9] M. Lipsitch,et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.
[10] Arturo Casadevall,et al. The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.
[11] R. Scheuermann,et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.
[12] Yonatan H. Grad,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[13] Jessica T Davis,et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.
[14] Yuntao Wu,et al. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.
[15] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[16] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[17] G. Gorse,et al. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses , 2020, Journal of medical virology.
[18] Yang Liu,et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[19] A. Hassan,et al. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 , 2020, Journal of Infection and Public Health.
[20] D. Cummings,et al. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.
[21] Wei Zhang,et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.
[22] Zhènglì Shí,et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, bioRxiv.
[23] D. Cummings,et al. Impacts of Zika emergence in Latin America on endemic dengue transmission , 2019, Nature Communications.
[24] B. Bosch,et al. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections , 2019, Emerging infectious diseases.
[25] M. V. Van Kerkhove,et al. Transmissibility of MERS-CoV Infection in Closed Setting, Riyadh, Saudi Arabia, 2015 , 2019, Emerging infectious diseases.
[26] M. Killerby,et al. Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014–2017 , 2019, Emerging infectious diseases.
[27] C. Midgley,et al. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia , 2019, Emerging infectious diseases.
[28] A. Tamin,et al. Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses , 2019, Scientific Reports.
[29] A. Tamin,et al. Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts—Abu Dhabi, United Arab Emirates , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] Zhènglì Shí,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[31] P. T. Ten Eyck,et al. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia , 2018, mBio.
[32] I. Jo,et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity , 2017, Diagnostic Microbiology and Infectious Disease.
[33] Kyoung-Ho Song,et al. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015 , 2017, Emerging infectious diseases.
[34] M. Koopmans,et al. Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Infection in Camel Workers in Qatar During 2013–2014: A Case-Control Study , 2017, The Journal of infectious diseases.
[35] Yufei Wang,et al. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants , 2016, Journal of Virology.
[36] Christl A. Donnelly,et al. Countering the Zika epidemic in Latin America , 2016, Science.
[37] R. Bruzzone,et al. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. , 2016, Hong Kong medical journal = Xianggang yi xue za zhi.
[38] S. Perlman,et al. Antibody Response and Disease Severity in Healthcare Worker MERS Survivors , 2016, Emerging infectious diseases.
[39] Serological Study of An Imported Case of Middle East Respiratory Syndrome and His Close Contacts in China, 2015 , 2016, Biomedical and Environmental Sciences.
[40] M. Ravid,et al. A Six-Year Follow-up Study , 2016 .
[41] E. Lau,et al. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea , 2015, Emerging infectious diseases.
[42] L. Ren,et al. Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection , 2015, Journal of Infection.
[43] Victor M Corman,et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study , 2015, The Lancet Infectious Diseases.
[44] C. Tse,et al. Global Spatio-temporal Patterns of Influenza in the Post-pandemic Era , 2014, Scientific Reports.
[45] Winnie Tu. The Burning Building , 2015 .
[46] Christian Drosten,et al. Evidence for camel-to-human transmission of MERS coronavirus. , 2014, The New England journal of medicine.
[47] M. Koopmans,et al. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen , 2014, International Journal of Antimicrobial Agents.
[48] Fu-Tong Liu,et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins , 2014, Biochemical and Biophysical Research Communications.
[49] Christian Drosten,et al. Serological assays for emerging coronaviruses: Challenges and pitfalls , 2014, Virus Research.
[50] Lisa E. Gralinski,et al. Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses , 2013, The Journal of infectious diseases.
[51] Z. Memish,et al. Investigation of Anti–Middle East Respiratory Syndrome Antibodies in Blood Donors and Slaughterhouse Workers in Jeddah and Makkah, Saudi Arabia, Fall 2012 , 2013, The Journal of infectious diseases.
[52] J. Peiris,et al. Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus , 2014, Virology Journal.
[53] R. Lu,et al. First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood , 2013, BMC Infectious Diseases.
[54] E. Walsh,et al. Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations , 2013, The Journal of infectious diseases.
[55] Shibo Jiang,et al. Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC , 2013, Journal of Infection.
[56] Herman Tse,et al. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests , 2013, Journal of Infection.
[57] M. Hou,et al. Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: Implications for the diagnosis of coronavirus infection , 2012, Journal of Virological Methods.
[58] B. Prabhakar,et al. Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing , 2012, PloS one.
[59] F. Ibrahim,et al. Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid (N)-based IgG ELISA assay for plasma samples from HIV-1 positive intravenous drug users (IDUs). , 2012, Acta medica Indonesiana.
[60] T. Kuijpers,et al. The dominance of human coronavirus OC43 and NL63 infections in infants , 2011, Journal of Clinical Virology.
[61] J. Peiris,et al. Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway , 2011, Journal of Virology.
[62] Pavel Dedera,et al. Mathematical Modelling of Study , 2011 .
[63] Hong Yang,et al. Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study , 2011, The Journal of Immunology.
[64] P. Simmonds,et al. Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method , 2010 .
[65] Shuying Wang,et al. Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies , 2009, Molecular Immunology.
[66] N Hens,et al. Seventy-five years of estimating the force of infection from current status data , 2009, Epidemiology and Infection.
[67] J. Crowe,et al. The Pediatric Burden of Human Coronaviruses Evaluated for Twenty Years , 2009, The Pediatric infectious disease journal.
[68] K. Yuen,et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus , 2009, Journal of Clinical Virology.
[69] P. Wang,et al. Determining SARS sub-clinical infection: A longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital , 2009, Scandinavian journal of infectious diseases.
[70] Weijun Chen,et al. The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus , 2008, BMC Microbiology.
[71] E. Severance,et al. Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population , 2008, Clinical and Vaccine Immunology.
[72] A. Falsey,et al. Long‐Term Care Facilities: A Cornucopia of Viral Pathogens , 2008, Journal of the American Geriatrics Society.
[73] K. Pyrć,et al. Human Coronavirus NL63 and 229E Seroconversion in Children , 2008, Journal of Clinical Microbiology.
[74] Yun Cheng,et al. Human LINE1 endonuclease domain as a putative target of SARS-associated autoantibodies involved in the pathogenesis of severe acute respiratory syndrome. , 2008, Chinese medical journal.
[75] R. Baric,et al. Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge , 2008, Journal of Virology.
[76] Y. Shao,et al. A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses , 2008, Diagnostic Microbiology and Infectious Disease.
[77] Ali Danesh,et al. Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.
[78] A. Vlasova,et al. Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nucleoprotein , 2007, Journal of Virology.
[79] Xiaojie Guo,et al. Seroepidemiology of group I human coronaviruses in children , 2007, Journal of Clinical Virology.
[80] W. Cao,et al. Disappearance of antibodies to SARS-associated coronavirus after recovery. , 2007, The New England journal of medicine.
[81] D. Dimitrov,et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies , 2007, Proceedings of the National Academy of Sciences.
[82] D. Ho,et al. Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Virology.
[83] J. A. Comer,et al. Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins , 2007, Clinical and Vaccine Immunology.
[84] Ze Chen,et al. Children’s vaccines do not induce cross reactivity against SARS-CoV , 2006, Journal of Clinical Pathology.
[85] J. Manson,et al. Prospective Study of , 2007 .
[86] M. Drebot,et al. An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. , 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[87] M. Han,et al. Cross-Protection against a Human Enteric Coronavirus and a Virulent Bovine Enteric Coronavirus in Gnotobiotic Calves , 2006, Journal of Virology.
[88] Shibo Jiang,et al. Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein , 2006, The Journal of Immunology.
[89] Wei Liu,et al. Two-Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome , 2006, The Journal of infectious diseases.
[90] S. Perlman,et al. Immunopathogenesis of coronavirus infections: implications for SARS , 2005, Nature Reviews Immunology.
[91] Jeng-Min Chiou,et al. Neutralizing Antibody Response and SARS Severity , 2005, Emerging infectious diseases.
[92] P. Woo,et al. Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63 , 2005, Clinical Diagnostic Laboratory Immunology.
[93] S. Au,et al. Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11 , 2005, Biochemical and Biophysical Research Communications.
[94] K. Tsao,et al. False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome , 2005, Journal of medical virology.
[95] P. Liao,et al. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity , 2005, Clinical and experimental immunology.
[96] Shibo Jiang,et al. Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus , 2005, Journal of Clinical Microbiology.
[97] C. Fraser,et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups , 2005, Epidemiology and Infection.
[98] S. Inoue,et al. Evaluation of Inapparent Nosocomial Severe Acute Respiratory Syndrome Coronavirus Infection in Vietnam by Use of Highly Specific Recombinant Truncated Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay , 2005, Clinical Diagnostic Laboratory Immunology.
[99] V. Cheng,et al. Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome—Associated Coronavirus and Human Coronaviruses 229E and OC43 , 2005, The Journal of infectious diseases.
[100] A. Carattoli,et al. Recombinant protein‐based ELISA and immuno‐cytochemical assay for the diagnosis of SARS† , 2005, Journal of medical virology.
[101] Zhihong Guo,et al. B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein , 2005, Journal of Virology.
[102] Kwanyee Leung,et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[103] W. Ehrengut,et al. A two year serological surveillance of coronavirus infections in Hamburg , 2005, Infection.
[104] A. Bradburne. Antigenic relationships amongst coronaviruses , 2005, Archiv für die gesamte Virusforschung.
[105] P. Hsueh,et al. Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS‐associated coronavirus , 2004, Clinical Microbiology and Infection.
[106] B. Moss,et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[107] Xinchun Chen,et al. Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome , 2004, The Journal of infectious diseases.
[108] Shiou-Hwei Yeh,et al. Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan , 2003, Emerging infectious diseases.
[109] Zhe Zhao,et al. A Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein , 2003, Genomics, Proteomics & Bioinformatics.
[110] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[111] E. Walsh,et al. Rhinovirus and Coronavirus Infection-Associated Hospitalizations among Older Adults , 2002, The Journal of infectious diseases.
[112] D. Tyrrell,et al. The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.
[113] D. Tyrrell,et al. The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[114] A. Nisalak,et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.
[115] J. Fox,et al. RISES IN TITERS OF ANTIBODY TO HUMAN CORONA VIRUSES OC43 AND 229E IN SEATTLE FAMILIES DURING 1975–1979 , 1986, American journal of epidemiology.
[116] C. Rosenfeld,et al. Isolation and propagation of a human enteric coronavirus. , 1986, Science.
[117] K. Callow. Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection , 1985, Journal of Hygiene.
[118] P. Saikku,et al. Age‐specific prevalence of complement‐fixing antibodies to sixteen viral antigens: A computer analysis of 58,500 patients covering a period of eight years , 2005, Journal of medical virology.
[119] S. Reed. The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: Evidence of heterogeneity among 229E‐related strains , 2005, Journal of medical virology.
[120] G. Gerna,et al. Antigenic Relatedness of Human Enteric Coronavirus Strains to Human Coronavirus OC43: A Preliminary Report , 1984, The Journal of infectious diseases.
[121] F. Scott,et al. Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever☆ , 1981, Comparative Immunology, Microbiology and Infectious Diseases.
[122] J. Gerdes,et al. Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E , 1981, Journal of virology.
[123] M. R. Macnaughton,et al. Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E , 1980, Journal of clinical microbiology.
[124] A. Salmi,et al. OC43 strain‐related coronavirus antibodies in different age groups , 2005, Journal of medical virology.
[125] H. S. Kaye,et al. Antigenic Relationship between Human Coronavirus Strain DC 43 and Hemagglutinating Encephalomyelitis Virus Strain 67N of Swine: Antibody Responses in Human and Animal Sera , 1977, The Journal of infectious diseases.
[126] A. Monto,et al. The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection , 1974, The Journal of infectious diseases.
[127] H. S. Kaye,et al. Detection of coronavirus 229E antibody by indirect hemagglutination. , 1972, Applied microbiology.
[128] M. Beem,et al. VIROLOGIC STUDIES OF ACUTE RESPIRATORY DISEASE IN YOUNG ADULTS , 1972, American journal of epidemiology.
[129] A. Monto,et al. Community-wide Outbreak of Infection with a 229E-like Coronavirus in Tecumseh, Michigan , 1970, The Journal of infectious diseases.
[130] D. Tyrrell,et al. Effects of a "new" human respiratory virus in volunteers. , 1967, British medical journal.
[131] D. Tyrrell,et al. Cultivation of a Novel Type of Common-cold Virus in Organ Cultures , 1965, British medical journal.
[132] M. Sherman,et al. A Preliminary Report , 1953 .